Medicine & TechnologyBrigham and Women's Hospital announced it would spearhead the first human trial of a nasal spray vaccine as a protection against Alzheimer's disease, formulated to prevent or delay the progression of the disease.
Eli Lily published detailed reports on the efficacy of Phase 2 clinical trials of donanemab, supporting the controversial amyloid hypothesis. Experts believe it could revolutionize Alzheimer's therapies.